Cannabis Dosing and Tolerability in AIMSS Treatment
Clinical Takeaway Topical cannabis balms were well tolerated in women with aromatase inhibitor-related joint and bone pain, addressing a common side effect that affects treatment adherence in breast cancer patients. This feasibility trial provides…
Topical Cannabis for AIMSS: Clinical Trial Evidence
Clinical Takeaway Topical cannabis balms were tolerable and feasible for women with aromatase inhibitor-related joint pain and stiffness, which affects about two-thirds of women taking these breast cancer medications. This approach could help improve…
Topical Cannabis for AIMSS: Cannabinoid Clinical Trial
Clinical Takeaway This small randomized trial tested whether topical cannabis balms were feasible and tolerable for managing joint pain and stiffness caused by aromatase inhibitors in postmenopausal breast cancer patients. The study found that topical…